SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2024 Biotech Charity Contest
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetium who wrote (39)2/15/2024 8:05:10 AM
From: Arthur Radley  Read Replies (2) of 195
 
What am I missing? I hold a 20% allocation in KALV and earlier in the week they announced what I thought was excellent Phase III results--the stock opened that day down $2.00, but clawed its way back to being even. Then turned down for the day. I hold a real position in the stock, but now they announced a secondary offering (which I understand will happen on the trial results.) But this is what I don't understand--the secondary was priced well above the closing cost. And now in the premarket this morning the stock is trading up more than $2.00. I'm not complaining---but can't remember doing a secondary with the offering placed above the going trading price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News